Back to search

Democritus University of Thrace (DUTH)

Κυτταρογενετικός έλεγχος σε ασθενείς με χρόνια νεφρική ανεπάρκεια

Abstract

dc:description

The purpose of this study was to identify the levels of Sister ChromatidExchanges (SCEs), if there is any cytostaticity or cytotoxicity, and moreoverthe possible instability of the genetic material in patients with Chronic RenalFailure after culturing of their peripheral blood lymphocytes of their blood.This study was done in 32 patients with CRF (with an average age of56.2 years old) from whom 18 had also a cancer, and furthermore in 18healthy blood donors (with an average age of 44.6 years old) from whom noone was a smoker or under the influence of drugs or virus infections.The samples were peripheral lymphocytes blood cultures with heparin,using 11 drops of blood in 5 ml chromosomal medium. After that, there wasan incubation at 37οC for 72 hours. Cell proliferation was allowed for at least 2mitotic cycles with the presence of BrdU in a final concentration of 5μg/ml andmitomycin C (MMC) in a final concentration of 15ng/ml added at the beginningof the cell cultures. After 70 hours, colcemide was added in a finalconcentration of 0,5 μg/ml for two hours, and at the end of the incubationperiod the cells were collected and Giemsa dye was applied (using themodified method FPG).There was an evaluation of the Proliferation Rate Index (PRI) of thelymphocytes as an index of cytostaticity, and an evaluation of Mitotic Indices(MI) as an index of cytotoxicity.There was a significant increase of the frequency of SCEs, estimatedat 9,23 SCEs/cell, in comparison to the frequency of the healthy donors wherethe average amount was 4.61 SCEs/cell. The increase percentage of SCEslevel was calculated at 100.2% (p<0,05).Furthermore, a decrease was observed at the PRIs and at the MIs arks(ΜΔ) of the patients, in comparison to those of the healthy donors. Thereduction of PRIs touched the percentage of 2,8%, which is particularly lowand it indicates the existence of a cytostaticity, in comparison to the reductionpercentage that was observed at the case of MIs, that was found 64,4% and itindicates a high cytotoxicity.It is important also to emphasize that there wasn’t any significantdifference at the above results between the patients with CRF and thepatients with CRF and cancer.Finally, by adding MMC there was a significant statistical increase ofthe SCEs (p<0,05) at the patients with CRF in comparison to healthy donors.That indicates the increased chromosomal fragility in the genetic material ofthese patients, a fact that leads to precaution and medication usage withcaution in patients with CRF.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2016

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Mavromatidou, Polyxeni
  • Μαυροματίδου, Πολυξένη

Subjects

dc:subject × 6

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/38274

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Mavromatidou, Polyxeni; Μαυροματίδου, Πολυξένη. Κυτταρογενετικός έλεγχος σε ασθενείς με χρόνια νεφρική ανεπάρκεια. Democritus University of Thrace (DUTH), 2016. http://hdl.handle.net/10442/hedi/38274